Morning Breakouts

Latest California Healthline Stories

DHS Weighing Extension of Drug Benefit Emergency Program

Advocates, legislative staff members and Department of Health Services officials are scheduled to meet later this week to discuss whether the state should continue California’s Medicare drug benefit. Sacramento Bee.

Governor’s Reform Plan Draws Fire From All Sides

Republican lawmakers oppose provisions of Gov. Schwarzenegger’s health proposal that call for employer and health provider contributions, while Democratic lawmakers want the governor to increase the percentage of employer contributions. Advocates for the poor are critical of provisions that would reward healthy lifestyles. Contra Costa Times et al.

Many Uninsured Qualify for Assistance, Do Not Enroll

Some people are unaware that they qualify for public programs, while others might have difficulty with long, complex enrollment forms or face delays in participation approval. AP/Seattle Post-Intelligencer.

Schwarzenegger Focused on Health Care Reform

Gov. Arnold Schwarzenegger said that he is focused on fixing California’s health care system and will not “get caught up” in the debate regarding his proposal for contributions from businesses. Stakeholders and commentators also weighed in on the proposal. Fresno Bee et al.

Budget Will Seek Slower Medicare Spending Growth

Treasury Secretary Paulson said that the fiscal year 2008 federal budget would include changes “aimed at slowing the growth” of Medicare spending and that he has discussed the issue with members of Congress. Wall Street Journal et al.

Obama Calls for Timetable for Universal Coverage

Sen. Barack Obama said the U.S. must evaluate whether the employer-based health insurance system is effective and consider other alternatives. Obama did not announce a universal health plan but said that he would be working to develop one. AP/Seattle Post-Intelligencer et al.

Lower Cost Estimated for Medicare Drug Benefit

The Congressional Budget Office said the program’s latest estimated cost is about 25% less than originally projected, largely because of lower-than-expected bids submitted by prescription drug plans. Bloomberg/Arkansas Democrat-Gazette et al.